AIAinitze Ibarzabal

Ainitze Ibarzabal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ainitze Ibarzabal has a total of 215 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Post-operative Metabolic Adaptation and its Influence on Long-Term Recurrent Weight Gain After Metabolic and Bariatric Surgery

    by Violeta Moizé, Paolo Piaggi, Inés Martínez-Saludes, Ferran Torres, Judit Viaplana, Amanda Jimenez, Ana de Hollanda, Ainitze Ibarzabal, Josep Vidal

  • Cerebrospinal fluid and plasma leptin dynamics following bariatric surgery in women

    by Adriana Pané, Laura Videla, Judith Viaplana, Ainitze Ibarzabal, Judith Molero, Violeta Moize, Sheila Lopez-Ruiz, Ana de Hollanda, Emilio Ortega, Isabel Barroeta, et al.

    Context: Impaired brain leptin transport is proposed as a mechanism in obesity-related leptin resistance. Objectives: We sought to evaluate plasma and cerebrospinal fluid (CSF) leptin dynamics before and 1 year after bariatric surgery (BS) and to explore their relationship with short-term weight loss and mid-term weight trajectories. Methods: In this prospective longitudinal cohort study conducted between 2017 and 2025 at a tertiary hospital, we included 33 women with obesity eligible for BS (OB-group) and 13 age-matched control women (HC-group). Study procedures were conducted at baseline and 1 year after BS, including dual-energy x-ray absorptiometry body composition analysis and plasma/CSF sampling. Leptin levels were measured, and the CSF-to-plasma leptin ratio was calculated to assess brain leptin transport efficiency. OB-group participants were followed annually for 4 years, with body weight recorded at each visit. Weight change from year 1 to 4 was calculated, along with weight regains (WR) from nadir weight to year 4. Results: At baseline, the OB-group exhibited elevated plasma and CSF leptin concentrations and reduced CSF-to-plasma leptin ratio. Following BS, leptin transport efficiency markedly improved. Although both plasma and CSF leptin decreased, the CSF leptin reduction was less pronounced. Neither baseline CSF leptin nor the CSF-to-plasma leptin ratio predicted weight loss at 1 year. Postsurgical CSF leptin levels and CSF-to-plasma leptin ratio were not associated with post-BS mid-term weight trajectories. Conclusion: Our findings indicate that obesity-related alterations in leptin transport are primarily attributable to the obese state rather than an intrinsic defect of the transport system and are potentially reversible through weight loss.

  • Time Free from High-Risk Obesity after One-Step Vs. Two-Step Duodenal Switch: A Propensity-Score Single-Center Analysis

    by Javier Osorio, David Merino, Lucia Sobrino, Nuria Vilarrasa, Ana Almeida, Amador García-Ruiz-De-Gordejuela, Ainitze Ibarzabal, Claudio Lazzara

    Background Duodenal switch (DS) can be performed as a direct one-stage procedure or as a planned/revisional two-step approach after sleeve gastrectomy. Consistent head-to-head evidence on long-term disease-free time is limited. Objectives To compare disease-free time and safety between direct (one-stage) and two-step DS. Setting Spanish tertiary bariatric center. Methods Propensity-score matched analysis (1:1) of patients undergoing DS, comparing direct versus two-step procedures. Matching variables were age, sex, and baseline body mass index (BMI). From 429 DS cases, 75 direct DS patients were matched to 75 two-step patients. Outcomes included short- and long-term complications, mortality, severe diarrhea or malnutrition, follow-up completeness at 3 and 5 years, weight loss, BMI < 35 kg/m², and disease-free status operationalized as the absence of metabolic diseases across follow-up. Results Mean initial BMI was 55.9 kg/m². Safety was comparable: short-term complications 14% (6% Clavien–Dindo ≥ III) and long-term 5.3%, with no between-group differences; no mortality, severe diarrhea, or malnutrition.Follow-up was 94.6% at 3 years and 80.7% at 5 years. Direct DS showed superior disease-free status at 5 years (absence of metabolic diseases 66.7% vs 57.1%; p<0.001) and greater durability of weight control (BMI < 35 kg/m² 88.2% vs 71.4%; p<0.001), along with higher total weight loss (45.4% vs 42.0%; p 50 kg/m², direct DS achieves longer high-risk disease-free status while maintaining a safety profile comparable to two-step DS.


  • Bariatric Surgery for Patients Living with Obesity and Left Ventricular Dysfunction: Evaluating Perioperative Safety and Postoperative Functional Outcomes

    by Iago Diéguez-Porto, Álvaro Barranco-De Santiago, Julia Vidal, Lilliam Flores, M Ángeles Castel, Ainize Ibarzabal, Eva Rivas, Graciela Martinez-Palli

    Introduction Obesity and heart failure with left ventricular ejection disfunction (LVED) are intertwined and rising worldwide. Weight loss through bariatric surgery improves cardiac function. We aimed to assess the incidence of perioperative complications in patients with severe obesity and LVED who had bariatric surgery, and the long-term effectiveness of surgery. Methods In a single-center observational retrospective study, we compared patients with body mass index ≥35 kg/m2 and LVED (defined as left ventricular ejection fraction (LVEF) < 50%) having bariatric surgery, to propensity-matched controls without LVED. The primary outcome was the incidence of complications during the initial 30 postoperative days. We also evaluated length of hospital stay, and weight loss, LVEF, and functional capacity one year after surgery. Results Overall, 79 patients were included, 38 with LVED (LVEF, 35 ± 9%) and 41 controls (LVEF, 59 ± 5%). There were not differences in baseline characteristics. The overall incidence of postoperative complications was similar. Patients with LVED had higher rate of minor complications (Clavien-Dindo grades 1 and 2, p < 0.05), which did not affect hospital length of stay (4 ± 5 vs. 3 ± 1 days) (p). After one year, bariatric surgery was effective with overall total weight loss of 34 ± 20%. Patients with LVED showed a 6 ± 10% increase in LVEF, and improvement in functional capacity. Conclusion Patients with LVED have higher incidence of minor complications after bariatric surgery with no impact on length of hospitalization. Bariatric surgery is associated with a significant improvement in both LVEF and functional capacity.

  • Hospital at Home for Early Home Transfer after Bariatric Surgery: A Propensity-Score Matched Study

    by Nils Jimmy Hidalgo, Irene Bachero, Paula González-Atienza, Victor Holguín, David Nicolás, Ainitze Ibarzabal

    Background Hospital at home (HaH) programs have demonstrated safety and efficiency in medical processes; however, few studies have examined their impact on surgical processes. This study aims to explore the feasibility and outcomes of the HaH program in postoperative bariatric surgery. Methods An exploratory retrospective study was conducted on patients undergoing bariatric surgery from March 1, 2021, to February 29, 2024. This study compared the outcomes of patients with conventional hospitalization (Hospital group) with those of patients who underwent early transfer to HaH (Hospital + HaH group). Propensity score matching, adjusted for confounding factors, was used to select the analyzed sample. Results A total of 687 patients who underwent bariatric surgery were identified. HaH was used in 231 patients (33.6%). After propensity score matching, 426 cases were included in the analysis: 207 from the Hospital group and 209 from the Hospital + HaH group. There were no statistically significant differences between the two groups in the rate of postoperative complications (p = 0.236), readmission 30 days after discharge (p = 1), and emergency consultation 30 days after discharge (p = 0.43). The total stay was longer in the Hospital group than in the Hospital + HaH group (2.4 ± 1.37 vs. 2.01 ± 0.1 days, p < 0.001). No patient was transferred from home to the hospital in the Hospital + HaH group. No mortality was reported in either group. A post hoc power calculation was 0.36. Conclusions HaH was associated with similar outcomes to those of conventional hospitalization, but statistical equivalence could not be demonstrated due to limited power. This study supports the feasibility of the HaH program in bariatric surgery, but confirmatory trials are needed.

  • Evaluating Protein Liquid Supplementation for Enhanced Protein Intake and Adherence at Short-Term After Metabolic and Bariatric Surgery: A Pilot Randomized Controlled Trial

    by Lucia Alonso, Isabella Gastaldo, Marc Caballero, Ferran Torres, Judit Molero, Alba Andreu, Ana de Hollanda, Ainitze Ibarzabal, Josep Vidal, Violeta Moizé

    Background The health benefits of metabolic and bariatric surgery (MBS) are associated with improvements in comorbidities and reduction in their incidence and mortality rates. Food restriction and anatomical changes result in a higher risk of nutritional complications and must be considered. This study aimed to evaluate the difference in adherence and daily protein intake between a protein liquid supplementation (PLS) versus a conventional protein powder (PPS) in patients undergoing (MBS). Methods A 2-month parallel, randomized, controlled trial including 50 patients (PLS n = 15; PPS n = 35) undergoing Roux-en-Y gastric bypass (GBP) was conducted. Body composition (bioimpedance analysis), resting energy expenditure (indirect calorimetry), and nutritional status (serum levels of macronutrients and micronutrients) were evaluated before pre- and post-operatively. Dietary protein intake and supplementation adherence were monitored every 15 days. Results Weight loss and changes in fat-free mass were comparable between the two groups after GBP (PLS: − 12.9 ± 4.8 vs. PPS: − 14.5 ± 6.3) (p > 0.05), (PLS: − 12.5 ± 3.7 vs. PPS: − 11.2 ± 3.3) (p > 0.05), respectively. The PLS group showed a higher basal metabolic rate at 2 months (PLS: 1843.4 ± 278.3 vs. PPS: 1642.2 ± 249.8) (p < 0.05). Adherence to the PLS group (102.7 ± 77.2%) was higher than the PPS group (42.0 ± 23.7%) (p = 0.012). Prevalence of 25OH-vitamin D deficiency and abnormal transferrin saturation were (PLS: 28.6% vs. PPS: 90% p < 0.001), (PLS: 8.3% vs. PPS: 57.1% p = 0.037), respectively. Conclusions A protein liquid supplementation appears to be an alternative in achieving the protein recommendations after GBP and may facilitate dietary adherence while reducing the incidence of nutritional deficiencies. This study is registered in ClinicalTrials.gov; no.[Blinded].


  • Obesity related pathophysiological aspects favouring Gastroesophageal Reflux Disease

    by Amador García Ruiz de Gordejuela, Ainitze Ibarzabal Olano, Carlos Gustavo Petrola Chacón, Óscar González López


  • Open Access

    Wilkie's syndrome as a rare upper intestinal obstruction cause

    by Anaïs Besa, Paula Domínguez-Garijo, Anna Curell, Jordi Farguell, Ainitze Ibarzábal, Xavier Morales, Dulce Momblan, Victor Turrado

  • Open Access

    Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease

    by Adriana Pané, Maria Claro, Alicia Molina-Andujar, Romina Olbeyra, Bárbara Romano-Andrioni, Laura Boswell, Enrique Montagud-Marrahi, Amanda Jiménez, Ainitze Ibarzabal, Judith Viaplana, et al.

    Obesity increases the risk of developing chronic kidney disease (CKD), which has a major negative impact on global health. Bariatric surgery (BS) has demonstrated a substantial improvement of obesity-related comorbidities and thus, it has emerged as a potential therapeutic tool in order to prevent end-stage renal disease. A limited number of publications to date have examined the beneficial effects and risks of BS in patients with non-advanced stages of CKD. We aimed to investigate the safety of BS in patients with CKD stages 3–4 (directly related or not to obesity) and both the metabolic/renal outcomes post-BS. A total of 57 individuals were included (n = 19 for CKD-group; n = 38 for patients with obesity, but normal eGFR [control-group]). Weight loss and obesity comorbidities resolution after BS were similar in both groups. Renal function (eGFR [CKD-EPI]) improved significantly at the 1-year follow-up: Δ10.2 (5.2–14.9) (p < 0.001) for CKD-group and Δ4.0 (−3.9–9.0) mL/min/1.73 m2 (p = 0.043) for controls. Although this improvement tended to decrease in the 5-year follow-up, eGFR remained above its basal value for the CKD-group. Noteworthy, eGFR also improved in those patients who presented CKD not directly attributed to obesity. For patients with CKD, BS appears to be safe and effective regarding weight loss and obesity comorbidities resolution, irrespective of the main cause of CKD (related or not to obesity).


  • Effects of Bariatric Surgery on Blood and Vascular Large Extracellular Vesicles According to Type 2 Diabetes Status

    by Adriana Pané, Judith Viaplana, Oriol Giró, Jaume Llopis, Ainitze Ibarzabal, Ana de Hollanda, Josep Vidal, Emilio Ortega, Amanda Jiménez, Gemma Chiva-Blanch

    Context: Large extracellular vesicles (lEVs) enriched for endothelial and blood cell markers are increased in metabolic conditions such as obesity or type 2 diabetes (T2D), actively contribute to the atherosclerotic process, and have been identified as diagnostic and prognostic biomarkers for cardiovascular disease (CVD). Although bariatric surgery (BS) in individuals with obesity is related to decreased cardiovascular (CV) risk and increased life expectancy, after BS these subjects are still at higher CV risk than the general population. Objective: We aimed to compare the lEV profiles between individuals with obesity, with or without T2D, before and 1 year after BS, and normal-weight controls. Methods: Prospective longitudinal study with individuals eligible for BS, with or without T2D (T2D and OB groups, respectively) and healthy controls (HC group) matched by age and sex. The concentration and phenotype of lEVs were assessed by flow cytometry. Results: The study cohort included 108 individuals (age 48.0 ± 10.5 years; 84.3% females). Before BS, the OB group presented higher concentrations of lEV enriched for endothelial and blood cell biomarkers than the HC group, but lower concentrations than those observed in the T2D group (P < .05). BS resulted in a significant reduction in most of the lEVs enriched for cell-specific markers in both subgroups. lEV differences between OB and T2D groups were no longer observed after BS (P > .05). However, compared with HC group, OB and T2D groups still showed increased concentrations of lEVs enriched for platelet and endothelial cell markers (P < .05). Conclusion: At 1 year after BS, lEV concentrations remain above the physiological range. These abnormalities might contribute to explaining the increased CV risk after BS and underscore the importance of long-term CV risk factor control in post-BS individuals.